The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTCN.L Regulatory News (TCN)

  • There is currently no data for TCN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.5 (EPT/NON-RI)

3 Aug 2021 11:55

RNS Number : 4263H
Arden Partners plc
03 August 2021
 

FORM 8.5 (EPT/NON-RI)

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY AN

EXEMPT PRINCIPAL TRADER WITHOUT RECOGNISED INTERMEDIARY ("RI") STATUS (OR WHERE RI STATUS IS NOT APPLICABLE)

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Arden Partners plc

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Tricorn Group plc

(c) Name of the party to the offer with which exempt principal trader is connected:

Tricorn Group plc

(d) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

2 August 2021

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

NO

If YES, specify which:

 

2. POSITIONS OF THE EXEMPT PRINCIPAL TRADER

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

10p ordinary

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

18,327

0.04%

(2) Cash-settled derivatives:

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

TOTAL:

18,327

0.04%

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

 

 

3. DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

10p ordinary

Sales

 

491

4.65p

4.65p

 

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

3 August 2021

Contact name:

Norman Gould

Telephone number:

020 7614 5935

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FEOEAEPDESEFEFA
Date   Source Headline
17th Sep 20215:39 pmRNSTricorn Group PLC
14th Sep 20217:00 amRNSUpdate on USA Payroll Protection Program loan
13th Sep 20217:00 amRNSNotice of Intention to Appoint Administrators
19th Aug 20212:43 pmRNSNotice of Intent and Change of Adviser
18th Aug 20219:30 amRNSStmt re Suspension and End of Formal Sale Process
18th Aug 20217:45 amRNSSuspension - Tricorn Group plc
11th Aug 202111:55 amRNSForm 8.5 (EPT/NON-RI)
10th Aug 20216:33 pmRNSForm 8.3 - Tricorn Group PLC
6th Aug 202111:36 amRNSForm 8.3 - Tricorn Group PLC
3rd Aug 202112:49 pmRNSDion Steward (Form 8.3 - Tricorn Goup plc)
3rd Aug 202112:48 pmRNSForm 8 (OPD) Tricorn Group plc
3rd Aug 202111:55 amRNSForm 8.5 (EPT/NON-RI)
3rd Aug 202111:02 amRNSForm 8.3 - Tricorn Group PLC
2nd Aug 20219:29 amRNSForm 8.3 - Tricorn Group plc
29th Jul 202111:58 amRNSForm 8.5 (EPT/NON-RI)
28th Jul 20217:00 amRNSCompany and Formal Sale Process Update
26th Jul 202112:32 pmRNSForm 8.3 - Tricorn Group plc
23rd Jul 202111:55 amRNSForm 8.5 (EPT/NON-RI)
22nd Jul 202112:03 pmRNSForm 8.5 (EPT/NON-RI)
22nd Jul 202111:59 amGNWForm 8.3 - [Tricorn Group plc - 21 07 2021 Opening Declaration] - (HHL)
21st Jul 20217:00 amRNSStrategic Review, including Formal Sale Process
30th Jun 20219:50 amRNSResult of Adjourned AGM
30th Jun 20217:00 amRNSFinal Results
28th Jun 20217:00 amRNSNotice of Annual Report and Interim Results
21st Jun 202112:41 pmRNSHolding(s) in Company
19th Apr 20217:01 amRNSReceipt of USA Payroll Protection Program loan
19th Apr 20217:00 amRNSChange of Adviser
12th Apr 20217:00 amRNSApproval of USA Payroll Protection Program loan
31st Mar 202111:04 amRNSResult of AGM
31st Mar 20217:00 amRNSUnaudited Preliminary Results
25th Mar 20217:00 amRNSCoronavirus Business Interruption Loan Scheme
19th Mar 202111:27 amRNSHolding(s) in Company
5th Mar 202110:00 amRNSNotice of AGM
25th Feb 20217:00 amRNSRe publication of audited final results
23rd Feb 202110:18 amRNSUpdate on USA Payroll Protection Program loan
29th Jan 20217:00 amRNSFurther Post-Period End and Q1 Trading Update
13th Jan 202111:45 amRNSHolding(s) in Company
11th Jan 20217:01 amRNSFurther Post-Period End Update
11th Jan 20217:00 amRNSDirectorate Changes
17th Dec 20205:44 pmRNSRe Intended Publication of Audited Accounts
7th Dec 20201:22 pmRNSFurther Post-Period End Update
16th Nov 20207:00 amRNSPost-Period End Update
6th Aug 20207:00 amRNSAward of Share Options
23rd Jun 20207:00 amRNSInterim Results
16th Jun 20209:00 amRNSAppointment of Group Finance Director
4th Jun 20207:00 amRNSTrading Update
2nd Apr 20201:05 pmRNSChange of Accounting Reference Date
20th Mar 202012:42 pmRNSCOVID-19 Impact
3rd Mar 20201:09 pmRNSDirectorate Change
25th Feb 20203:25 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.